Overview

Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout

Status:
Not yet recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
D-0120 is being tested in combination with Allopurinol in adult subjects with Gout.
Phase:
Phase 2
Details
Lead Sponsor:
InventisBio Co., Ltd